List of works - Christos S Karapetis

A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.

scientific article published on 26 January 2018

A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.

scientific article published on 18 September 2012

Acanthosis Palmaris: A Rare Paraneoplastic Manifestation of Non-Small-Cell Lung Cancer.

scientific article published on 22 January 2018

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

scientific article published on 26 February 2018

Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model

scientific article

Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies

scientific article

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

scientific article published on 08 November 2012

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer

scientific article

Author's Reply

Authors' Reply to Yu: "Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry"

scientific article published on 01 June 2019

BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?

scientific article published on 29 December 2015

Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry.

scientific article published in November 2017

Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation.

scientific article

Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy

scientific article published on 19 June 2019

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

scientific article

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study

scientific article published on 08 June 2018

Cetuximab in metastatic colorectal cancer.

scientific article published on May 2012

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer

scientific article published on 07 January 2020

Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.

scientific article published on 13 November 2013

Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly.

scientific article published on 3 June 2016

Colorectal cancer: Metastases to a single organ

scientific article

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

scientific article published on 5 July 2010

Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry

article

Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies

scientific article

Copy number profiles of paired primary and metastatic colorectal cancers

scientific article published on 15 December 2017

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

scientific article published on 25 September 2015

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

scientific article

Current opinion on optimal treatment for colorectal cancer.

scientific article published on May 2013

Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer.

scientific article

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

scientific article published on 16 July 2013

Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry

article

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

scientific article published on 14 August 2015

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

scientific article published on 6 November 2014

Dose Modification for Haematological Toxicity: A survey of Australian Medical Oncologists

scientific article published on 07 December 2019

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

scientific article published on 8 September 2017

Early stage ovarian cancers: angiogenesis inhibition and clear cell cancers

scientific article published on 16 August 2011

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab

scientific article published on 01 December 2019

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials

scientific article published on 11 December 2019

Epidemiology of neuroendocrine cancers in an Australian population.

scientific article published on 24 April 2010

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

scientific article published on 12 December 2013

Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia.

scientific article published in October 2014

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials

scientific article published on 15 April 2019

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

scientific article published on 12 August 2014

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

scientific article

Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly

scientific article

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.

scientific article published on 2 December 2013

First-line therapy for metastatic colorectal cancer: Current perspectives and future directions

scientific article published on 01 February 2019

Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.

scientific article published on 29 November 2016

Goserelin toxicities and preferences for ovarian suppression method in pre-menopausal women with breast cancer.

scientific article published on 8 July 2016

Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.

scientific article published on 18 January 2018

Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response

scientific article published on 01 December 2018

Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing

scientific article published on 09 July 2018

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.

scientific article published on 12 July 2015

Internet use and preferences among women living with advanced breast cancer

scientific article published on 21 February 2019

Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry

scientific article published on June 2016

Is self-management feasible and acceptable for addressing nutrition and physical activity needs of cancer survivors?

scientific article published on 28 December 2014

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

scientific article published on 16 September 2014

Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.

scientific article published in November 2013

Localized prostate cancer in elderly men aged 80-89, findings from a population-based registry.

scientific article published on 30 March 2018

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

scientific article published on 12 May 2015

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying

scientific article published on 01 July 2018

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.

scientific article

Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer

scientific article

Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades.

scientific article published on January 2015

Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.

scientific article published on 30 July 2015

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

scholarly article

Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer

scientific article published on 01 June 2018

Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience

scientific article published on 22 June 2018

Online information and support needs of women with advanced breast cancer: a qualitative analysis.

scientific article

Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small-cell lung cancer: an open-label phase II multicentre trial (COVeRT study).

scientific article published on 3 September 2015

Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

scientific article published on 24 July 2009

Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry

article

Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20

scientific article published on 28 November 2018

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

scientific article published on 02 July 2012

PHASE IB/II STUDY OF SECOND LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN KRAS WILD TYPE METASTATIC COLORECTAL CANCER.

scientific article published on 8 May 2018

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

scientific article

Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.

scientific article published on 19 January 2017

Personalized treatment for advanced colorectal cancer: KRAS and beyond

scientific article

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

scientific article published on 03 December 2019

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

scientific article published on 05 May 2019

Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer.

scientific article

Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia

scientific article published on 29 August 2019

Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.

scientific article published on 27 March 2015

Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer

scientific article

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.

scientific article published on 24 August 2017

Pregnancy screening prior to chemotherapy administration

scientific article

Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data

scientific article published on 01 May 2019

Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment

scientific article published on 10 May 2018

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer.

scientific article published on 11 November 2015

Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival

scientific article published on 10 July 2018

Reply: Comment on 'Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'.

scientific article published on 10 September 2015

Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC

scientific article published on 07 June 2019

Returning to work following curative chemotherapy: a qualitative study of return to work barriers and preferences for intervention.

scientific article

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

scientific article published on 15 October 2018

SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

scientific article published on 17 December 2019

Serum vitamin D decreases during chemotherapy: an Australian prospective cohort study

article

Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.

scientific article

South Australian clinical registry for metastatic colorectal cancer.

scientific article

Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow up

scientific article published on 01 October 2019

Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.

scientific article published on 3 July 2012

Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.

scientific article

Targeted therapy for esophagogastric cancers: a review

scientific article

Targeted therapy for metastatic colorectal cancer

scientific article published on 03 August 2018

The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology

scientific article published on 24 October 2018

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers

scientific article published on 24 July 2018

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

scientific article published on 21 November 2019

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

scientific article published on 08 April 2014

The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17.

scientific article published on 5 February 2014

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials

scientific article

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

scientific article published on 23 July 2018

Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival

scientific article published on 30 September 2019

Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.

scientific article published on 24 March 2016

Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.

scientific article published on 4 May 2017

Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.

scientific article published on 30 June 2016

Validation of companion diagnostic for detection of mutations in codons 12 and 13 of the KRAS gene in patients with metastatic colorectal cancer: analysis of the NCIC CTG CO.17 trial.

scientific article published on 3 October 2012

Very high GFR in cancer patients undergoing chemotherapy: prevalence, carboplatin dosing patterns and chemotherapy toxicity.

scientific article published on September 2011

List of works by Christos S Karapetis

A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.

A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.

Acanthosis Palmaris: A Rare Paraneoplastic Manifestation of Non-Small-Cell Lung Cancer.

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model

Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer

Author's Reply

Authors' Reply to Yu: "Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry"

BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?

Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry.

Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation.

Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study

Cetuximab in metastatic colorectal cancer.

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer

Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.

Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly.

Colorectal cancer: Metastases to a single organ

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry

Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies

Copy number profiles of paired primary and metastatic colorectal cancers

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Current opinion on optimal treatment for colorectal cancer.

Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer.

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Dose Modification for Haematological Toxicity: A survey of Australian Medical Oncologists

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

Early stage ovarian cancers: angiogenesis inhibition and clear cell cancers

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials

Epidemiology of neuroendocrine cancers in an Australian population.

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia.

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.

First-line therapy for metastatic colorectal cancer: Current perspectives and future directions

Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.

Goserelin toxicities and preferences for ovarian suppression method in pre-menopausal women with breast cancer.

Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.

Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response

Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.

Internet use and preferences among women living with advanced breast cancer

Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry

Is self-management feasible and acceptable for addressing nutrition and physical activity needs of cancer survivors?

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.

Localized prostate cancer in elderly men aged 80-89, findings from a population-based registry.

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.

Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer

Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades.

Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer

Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience

Online information and support needs of women with advanced breast cancer: a qualitative analysis.

Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small-cell lung cancer: an open-label phase II multicentre trial (COVeRT study).

Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry

Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

PHASE IB/II STUDY OF SECOND LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN KRAS WILD TYPE METASTATIC COLORECTAL CANCER.

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.

Personalized treatment for advanced colorectal cancer: KRAS and beyond

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)